Clinical trial
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer (REDEEM-CAD)
NCT05366153 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer (REDEEM-CAD)
- Lead sponsor
- Baker Heart and Diabetes Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 18, 2023
- Completion date
- May 31, 2026
- Enrollment
- 748 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.